InvestorsHub Logo
Followers 10
Posts 2085
Boards Moderated 0
Alias Born 05/15/2015

Re: Whalatane post# 3024

Thursday, 07/27/2017 11:11:59 AM

Thursday, July 27, 2017 11:11:59 AM

Post# of 3329
Okay. But Auryxia is a phosphate binder for patients with CKD. The helping with the iron issues was a good secondary outcome and patients would need just the one drug, rather than two, which is great for keeping costs down.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.